Collaboration
Qiagen and Bayer Healthcare Collaborate on Development of Companion Diagnostics
Qiagen and Bayer HealthCare have announced a collaboration agreement to develop and commercialize companion diagnostics paired with Bayer HealthCare drugs. The initial focus will be on enhancing the treatment of various solid tumors, according to a press release posted on the Qiagen website. Development of novel technologies for patient profiling that may result in innovative research-use-only products for exploratory and translational medicine are also part of the deal. Financial details were...
PerkinElmer, TPM Biotech to Validate Detection Kits for Food Screening
PerkinElmer Inc. has entered into an agreement with TPM Biotech SDN. BHD. (TPMB), a Malaysian laboratory for Halal food testing services, to explore potential applications of PerkinElmer's Porcine Detection Kits and chromatography solutions for use in validating methods of testing food products for compliance with Halal certification regulations. PerkinElmer recently launcehd its Porcine Detection Kit as a solution for testing laboratories to provide...
Luminex, Bio-Rad Extend Sales and Distribution Agreement
Luminex Corp. has extended its global sales and distribution agreement with Bio-Rad Laboratories Inc. to 2023. In addition, Luminex has granted Bio-Rad global sales and distribution rights for Luminex's MAGPIX multiplexing instrument. As part of the agreement, Bio-Rad will now offer the full range of Luminex's xMAP systems including the MAGPIX system, a compact, flexible instrument that simultaneously detects up to 50 different analytes, including proteins and nucleic acids, on a single...
Bristol-Myers Squibb, Meso Scale Discovery to Develop Assays for Alzheimer’s Disease
Bristol-Myers Squibb Company and Meso Scale Discovery have entered an agreement to develop diagnostic assays that will measure cerebrospinal fluid biomarkers for use in Alzheimer’s disease research. Under the terms of the agreement, the companies will develop these assays based on the Meso Scale Discovery MULTI-ARRAY technology platform. Meso Scale Discovery will commercialize the assays for Alzheimer’s disease research and drug development, and plans to release the assays in the...
DiaGenic, GE Healthcare to Develop Test for Mild Cognitive Impairment
DiaGenic ASA announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic’s peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease. The study would be used in conjunction with PET imaging to identify a blood based gene expression signature in these patients. The PET imaging agent, [18F] Flutemetamol, is currently in phase 3 development and is not yet...
Opko Health Expands Collaboration with Arctic Partners
Opko Health Inc. announced an expansion of the previously announced exclusive licensing deal with Arctic Partners Ab Oy (Turku, Finland) for two biomarkers in the kallikrein family which used together with prostate specific antigen (PSA)can reduce the need for prostate biopsies by over 50%. Opko exercised a right of first refusal to secure additional proprietary information, patents, know-how, property and technology associated with time-resolved fluorescence detection technology, which is...
Agilent Technologies, FDA Collaborate to Improve Salmonella Testing
Agilent Technologies Inc. has entered into a Cooperative Research and Development Agreement with FDA to develop new tools to detect and analyze pathogens in food. The joint R&D effort will also seek to improve DNA-based tools for confirming that seafood is correctly labeled. The goal of the first part of the project is to develop a novel assay panel to identify subtypes of salmonella in food. The research will focus on using mass spectrometry-based genotyping to quickly identify salmonella...
ZyGem, Lockheed Martin Announce Release of DNA Analysis Platform
Lockheed Martin and ZyGem Corp. Ltd. plan to release a version of their rapid DNA analysis platform that is designed to simplify and speed DNA analysis for human identity testing. Pre-production units of the platform will be released this summer to select customers in the forensic, homeland security and intelligence communities. The companies recently unveiled a compact cartridge device that is a key component of the rapid DNA analysis platform during the Annual Scientific Meeting of the...
Qiagen, KingMed Diagnostics Reach Marketing Agreement
Qiagen NV will expand access to its digene HPV Test across China through a co-marketing agreement with KingMed Diagnostics, China's largest independent laboratory network. Through the agreement, KingMed Diagnostics will function as a centralized lab, allowing smaller hospitals and those in less-populated areas to offer the digene HPV Test and send samples to KingMed Diagnostics for processing and analysis. The agreement is an additional milestone for Qiagen's molecular diagnostics franchise in...
Mayo Clinic Collaborates on Progranulin Test for Dementia
Mayo Clinic announced that Mayo Medical Laboratories has signed an agreement with A&G Pharmaceutical Inc. and will receive a non-exclusive license to certain patent rights and proprietary antibody reagents for the detection and measurement of progranulin in blood. This agreement will let Mayo Clinic offer the first commercial blood test to predict progranulin mutation status in patients suspected to have frontotemporal dementia (FTD). The blood test will be available in late 2012 for all...